CD8A and neoplasm: Similarly, cancer specific transcription induced chimeric RNA loaded Dex have demonstrated the ability to enhance CD8+ T cell mediated antitumor immunity and suppress tumor progression in esophageal cancer (Xiong et al. 2022).